Nuwellis, Inc. · NASDAQ:NUWE

Nuwellis — Sunshine Heart — TCT 2013

39 slides from Nuwellis's conference presentation, Oct 29, 2013

  1. Slide 1: Progress of the Fully Implantable System

    © 2013 Sunshine Heart, Inc. Progress of the Fully Implantable System TCT – October 2013 www.sunshineheart.com

  2. Slide 2: Forward Looking Statement

    Forward Looking Statement This presentation contains forward-looking statements. All forward-looking statements are management’s present expectations of future events and are subject to a number of risks and uncertainties. Various factors could cause actual results to differ materially from these st

  3. Slide 3: C-Pulse II Overview

    C-Pulse II - Fully Implantable System Internal electro-hydraulic converter eliminates the percutaneous drive line and associated infection risks. Non-blood contacting Non-obligatory CAUTION: Investigational device, limited by Federal (or United States) Law to Investigational Use C-Pulse II Overview

  4. Slide 4: C-Pulse II Overview

    C-Pulse II - Fully Implantable System Internal electro-hydraulic converter eliminates the percutaneous drive line and associated infection risks. Non-blood contacting Non-obligatory No percutaneous drive line CAUTION: Investigational device, limited by Federal (or United States) Law to Investigation

  5. Slide 5: C-Pulse II Overview

    CAUTION: Investigational device, limited by Federal (or United States) Law to Investigational Use C-Pulse II Overview: C-Pulse II - Fully Implantable System Internal electro-hydraulic converter eliminates the percutaneous drive line and associated infection risks. Non-blood contacting Non-obligatory

  6. Slide 6: Freedom From VAD Exit Site Infection

    Freedom From VAD Exit Site Infection 01/01/1996 to 12/31/2008 Entire Cohort [9.22 [s.18 [5.38 ‘Cumulative Proportion Free of infection 30 60 90 120 150 180 210 240 270 300 330 360 390 420 450 ‘Survival Time (days)

  7. Slide 7: Eliminating the driveline is not a new idea... Circa 1985

    Eliminating the driveline is not a new idea... © 2012 Sunshine Heart, Inc. Circa 1985

  8. Slide 8: Arrow LionHeart LVAD First clinical TETS system

    Arrow LionHeart LVAD First clinical TETS system

  9. Slide 9: Arrow LionHeart LVAD First clinical TETS system

    Arrow LionHeart LVAD First clinical TETS system

  10. Slide 10: Arrow LionHeart LVAD First clinical TETS system

    Arrow LionHeart LVAD First clinical TETS system

  11. Slide 11: Where will clinical implementation of TETS technology first find traction?

    © 2013 Sunshine Heart, Inc. Where will clinical implementation of TETS technology first find traction?

  12. Slide 12: SUNSHINE HEART C-pulse juxta-aortic balloon

    © 2013 Sunshine Heart, Inc. SUNSHINE HEART C-pulse juxta-aortic balloon

  13. Slide 13: [LOGO]

    [LOGO]

  14. Slide 14: ?

    ?

  15. Slide 15: C-pulse juxta-aortic balloon: non-obligatory, no blood contact

    © 2013 Sunshine Heart, Inc. SUNSHINE HEART C-pulse juxta-aortic balloon Non-obligatory No blood contact so...

  16. Slide 16: SUNSHINE HEART C-pulse juxta-aortic balloon

    © 2013 Sunshine Heart, Inc. SUNSHINE HEART C-pulse juxta-aortic balloon

  17. Slide 17: SUNSHINE HEART C-pulse II

    SUNSHINE HEART C-pulse II © 2013 Sunshine Heart, Inc.

  18. Slide 18: SUNSHINE HEART C-pulse II

    SUNSHINE HEART C-pulse II

  19. Slide 19: Electrohydraulic pump...

    ] Electrohydraulic pump...

  20. Slide 20: C-Pulse II – Leveraging powerful synergies

    C-Pulse II – Leveraging powerful synergies Minnetronix Cirtec Medical Systems TEXAS HEART INSTITUTE at St. Luke’s Episcopal Hospital

  21. Slide 21: Electrohydraulic pump

    Electrohydraulic pump- Rapidly inflates and deflates the juxta-aortic balloon (reproduces C-I physiology) EKG synchronized to provide counter-pulsation Balloon passively empties in the event of pump or power failure (essential) Leverages the incompressibility of silicone oil Compliance reservoir inc

  22. Slide 22: C-Pulse II – Important IP progress

    C-Pulse II – Important IP progress

  23. Slide 23: Cirtec Medical Systems Electrohydraulic pump

    Cirtec Medical Systems Electrohydraulic pump-

  24. Slide 24: How are we going to power it?

    How are we going to power it? ll '

  25. Slide 25: Trans-cutaneous Energy Transfer System (TETS)

    Trans-cutaneous Energy Transfer System (TETS) DC battery pack outside the body DC current is put through an oscillator to make AC AC current is put through a large electro-magnetic coil (1o) to generate an oscillating magnetic field Oscillating magnetic field goes through the skin Oscillating magnet

  26. Slide 26: Standard transformer

    Standard transformer Cc SUNSHINE

  27. Slide 27: Inductive coupling through an air-gap

    Inductive coupling through an air-gap

  28. Slide 28: Nikola Tesla

    July 10, 1856 – January 7, 1943 Nikola Tesla

  29. Slide 29: Newest TETS systems: smaller, more efficient, more tolerant

    Newest systems are: Smaller size so easier to implant More energy efficient so improved battery life More tolerant of geometric misalignment © 2013 Sunshine Heart, Inc. Minnetronix Leaders in Transcutaneous Energy Transfer Systems (TETS)

  30. Slide 30: Minnetronix Leaders in Transcutaneous Energy Transfer Systems (TETS)

    Minnetronix Leaders in Transcutaneous Energy Transfer Systems (TETS)

  31. Slide 31: Improvement in TETS component geometry and function

    Improvement in TETS component geometry and function Minnetronix

  32. Slide 32: Improvement in TETS component geometry and function

    Improvement in TETS component geometry and function Minnetronix

  33. Slide 33: Where are we going to test it?

    Where are we going to test it? ~~ |

  34. Slide 34: Texas Heart Institute at St. Luke’s Episcopal Hospital

    TEXAS HEART INSTITUTE at St. Luke’s Episcopal Hospital

  35. Slide 35: THI Cardio Vascular Research Lab ICU

    THI Cardio Vascular Research Lab ICU

  36. Slide 36: THI Cardio Vascular Research Lab ICU

    THI Cardio Vascular Research Lab ICU

  37. Slide 37: Surgical Implant and System Integration

    Surgical Implant and System Integration THI’s Cardio Vascular Research Lab The premiere large animal cardiovascular research lab in the world Domain dominance in development and implementation of heart failure technology Successful acute system implantation (first generation) 36 © 2013 Sunshine Hear

  38. Slide 38: Minimally Invasive Implantation

    Minimally Invasive Implantation Small incision Sternal-sparing No cardiopulmonary bypass

  39. Slide 39: In summary

    The SUNSHINE HEART C-Pulse II has the potential to be the first completely self-contained therapy for heart failure since the bi-ventricular pacer Lack of blood contact and non-obligatory feature make it the most likely candidate to leverage TETS in a mechanical circulatory assist device Pump innova

Sunshine Heart — TCT 2013 on 6ix